Picture of Geovax Labs logo

GOVX — Geovax Labs News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Geovax Completes Enrollment Of Phase 2 Trial For Next-Generation COVID-19 Vaccine Booster

Sept 11 (Reuters) - GeoVax Labs Inc  GOVX.O :
    * GEOVAX COMPLETES ENROLLMENT OF PHASE 2 TRIAL FOR
NEXT-GENERATION
COVID-19 VACCINE BOOSTER

Source text for Eikon:  ID:nGNX1Pm8sQ 
Further company coverage:  GOVX.O 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Geovax Labs

See all news